Grown Rogue International (GRUSF) Revenue (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) Revenue (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.14% |
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -407.63% |
| Sep 30, 2025 | -100.00% |
| Jun 30, 2025 | 77,753,716,233,456.55% |
| Mar 31, 2025 | -73.14% |
| Dec 31, 2024 | 419.35% |
| Sep 30, 2024 | -9.16% |
| Jun 30, 2024 | -15.20% |
| Mar 31, 2024 | 82.91% |
| Oct 31, 2023 | 53.03% |
| Jul 31, 2023 | 104.85% |
| Apr 30, 2023 | 32.54% |
| Jan 31, 2022 | -0.73% |
| Oct 31, 2021 | 24.14% |
| Jul 31, 2021 | 96.89% |
| Apr 30, 2021 | 46.35% |
| Jan 31, 2021 | -0.52% |
| Oct 31, 2020 | 16.89% |
| Jul 31, 2020 | -22.91% |